Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 650, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-06-23
DOI
10.1126/scitranslmed.abn8238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins
- (2021) Peyman Esmaili-Shahzade-Ali-Akbari et al. NEUROTOXICOLOGY
- Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder
- (2021) Eric C. Strain et al. JAMA Psychiatry
- ASSESSMENT OF CRAVING IN OPIOID USE DISORDER: PSYCHOMETRIC EVALUATION AND PREDICTIVE VALIDITY OF THE OPIOID CRAVING VAS
- (2021) Brent Boyett et al. DRUG AND ALCOHOL DEPENDENCE
- Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.
- (2021) Andrew S. Huhn et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Wireless electroencephalography (EEG) to monitor sleep among patients being withdrawn from opioids: Evidence of feasibility and utility.
- (2021) Kelly E. Dunn et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Bidirectional relationship between opioids and disrupted sleep: putative mechanisms
- (2020) D. Eacret et al. MOLECULAR PHARMACOLOGY
- Effects of orexin receptor antagonism on human sleep architecture: A systematic review
- (2020) Jacob W. Clark et al. SLEEP MEDICINE REVIEWS
- Alteration of orexin-A and PKCα in the postmortem brain of pure-opioid and multi-drug abusers
- (2020) Mitra-Sadat Sadat-Shirazi et al. NEUROPEPTIDES
- Differences in patient-reported and observer-rated opioid withdrawal symptom etiology, time course, and relationship to clinical outcome
- (2020) Kelly Dunn et al. DRUG AND ALCOHOL DEPENDENCE
- Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015
- (2020) Kevin Y. Xu et al. JAMA Network Open
- Helping to End Addiction Over the Long-term
- (2018) Francis S. Collins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy
- (2018) Thomas C. Thannickal et al. Science Translational Medicine
- Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients
- (2018) Andrew S. Huhn et al. NEUROPSYCHOPHARMACOLOGY
- The Accuracy, Night-to-Night Variability, and Stability of Frontopolar Sleep Electroencephalography Biomarkers
- (2017) Daniel J. Levendowski et al. Journal of Clinical Sleep Medicine
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
- (2017) Michael J. Sateia et al. Journal of Clinical Sleep Medicine
- Efficacy of Tramadol Extended-Release for Opioid Withdrawal
- (2017) Kelly E. Dunn et al. JAMA Psychiatry
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. BIOLOGICAL PSYCHIATRY
- STOP-Bang Questionnaire
- (2016) Frances Chung et al. CHEST
- Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study
- (2016) Kerri A. Schoedel et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
- (2016) Ellen Snyder et al. SLEEP MEDICINE
- Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity
- (2015) C. Baimel et al. JOURNAL OF NEUROSCIENCE
- Sleep-disordered breathing decreases after opioid withdrawal
- (2015) Andreas Schwarzer et al. PAIN
- Actigraphy combined with EEG compared to polysomnography in sleep apnea patients
- (2015) Ingo Fietze et al. PHYSIOLOGICAL MEASUREMENT
- Orexin/hypocretin role in reward: implications for opioid and other addictions
- (2014) Corey Baimel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sleep Profile in Opioid Dependence
- (2014) Vijay Mehtry et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine
- (2014) Leila Zarepour et al. NEUROPEPTIDES
- Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats
- (2013) S. Mohammad Ahmadi-Soleimani et al. NEUROSCIENCE LETTERS
- Polydrug abuse: A review of opioid and benzodiazepine combination use
- (2012) Jermaine D. Jones et al. DRUG AND ALCOHOL DEPENDENCE
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring
- (2012) Colleen E. Carney et al. SLEEP
- Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone
- (2010) David Andrew Tompkins et al. PSYCHOPHARMACOLOGY
- Role of orexin/hypocretin in dependence and addiction
- (2009) Ruth Sharf et al. BRAIN RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started